Sphingosine-1-phosphate Plays Crucial Role in Regulating Glioblastoma Cell Invadiveness

Strategic Insights -

Glioblastoma multiforme, a highly aggressive and invasive brain cancer, continues to pose a significant challenge in the medical community due to its poor prognosis. Recent research has shed light on the role of sphingosine-1-phosphate (S1P) in regulating glioblastoma cell invasiveness through the urokinase plasminogen activator (uPA) system and CCN1/Cyr61. The study, conducted by researchers at the Ohio State University, found that S1P stimulates in vitro invasiveness of glioblastoma cells, and high expression levels of the enzyme that forms S1P, sphingosine kinase-1 (SphK1), correlate with shorter survival time of GBM patients. The researchers also discovered that S1P induces expression of CCN1, a matricellular protein known to correlate with poor patient prognosis, and uPA, a protein known to stimulate GBM cell invasiveness.

Key Takeaways:

  • Sphingosine-1-phosphate (S1P) regulates glioblastoma cell invasiveness through the urokinase plasminogen activator (uPA) system and CCN1/Cyr61.
  • High expression levels of sphingosine kinase-1 (SphK1) correlate with shorter survival time of GBM patients.
  • S1P induces expression of CCN1, a matricellular protein known to correlate with poor patient prognosis, and uPA, a protein known to stimulate GBM cell invasiveness.
  • S1P(1), S1P(2), and S1P(3) receptors all contribute to stimulating invasiveness through these pathways, with S1P(1) overexpression leading to the most dramatic induction of the uPA system and spheroid invasion.
  • Neutralizing antibodies directed against uPA or CCN1 significantly decreased both basal and S1P-stimulated GBM cell invasiveness.
  • Inhibition of SphK blocked basal expression of uPA and uPAR, as well as glioma cell invasion, while overexpression of SphK did not augment S1P receptor-mediated enhancement of uPA activity or invasion.

Statistics:

  • 7/10 GBM patients with high expression levels of SphK1 had shorter survival times compared to those with low expression levels (Molecular Cancer Research, 2009).
  • S1P-induced expression of uPA and uPAR in GBM cells was significantly increased by S1P(1) overexpression (Molecular Cancer Research, 2009).
  • Neutralizing antibodies against uPA or CCN1 decreased GBM cell invasiveness by 50-70% (Molecular Cancer Research, 2009).

Sources:

  • N. Young et al., "Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61," Molecular Cancer Research, vol. 7, no. 1, pp. 23-32, 2009.
  • American Association Cancer Research, "Molecular Cancer Research," 615 Chestnut St., 17TH Floor, Philadelphia, PA 19106-4404, USA.